Adding Warnings To Labeling Will Be More Complicated Under Final Rule
Executive Summary
Labeling changes, especially the addition of warnings, could be complicated under FDA's new physician labeling because of the requirement to obtain a prior approval supplement (PAS) before revisions to the Highlights section can be finalized